Showing 771 - 780 of 784 for "Life sciences" with applied filters
05 June 2019 by
Alexander Robinson and Stephen Garner of Mathys & Squire explore some of the regulatory issues in the life sciences and pharmaceutical sectors that are likely to be affected by Brexit
16 May 2019 by
Paul A Ainsworth and Lauren A Watt of Sterne Kessler Goldstein & Fox examine the extent to which the proposed Biologic Patent Transparency Act will reduce patent thickets, increase transparency and competition in the biologics industry.
27 February 2019 by
Duo will join New York office, adding patent litigation expertise
23 November 2018 by
Ilya Kazi and Miranda Kent of Mathys & Squire analyse the changes to the EPO’s opposition procedure and suggest ways in which businesses can align their strategy with the current legal tools available
24 September 2018 by
Novartis and the NHS’ recent agreement concerning CAR-T therapy is a positive step for adoptive immunotherapy. However, while the future looks bright, the therapy is also subject to threats. Frances Salisbury and Adam Gregory of Mewburn Ellis discuss successes and potential Brexit-related hurdles
01 September 2018 by
On June 28 2018 the Zimbabwean authorities published a document entitled the Zimbabwe Intellectual Property Policy and Implementation Strategy.
01 September 2018 by
About 47% of the land area of the Philippines is devoted to agriculture. The agriculture sector can be divided into four groups: farming, fisheries, livestock, and forestry.
14 May 2018 by
This roundup features Antequera Parilli & Rodriguez, Arochi & Lindner, Bardehle Pagenberg, DWF, FisherBroyles, HGF, J A Kemp, Kirkland & Ellis, Lewis Silkin, Marks & Clerk, Pinsent Masons and Santarelli
02 April 2018 by
This roundup features Awapatent, Covington & Burling, Dentons, EIP, Eversheds Sutherland, Gowling WLG, Hoyng Rokh Monegier, Mewburn Ellis, Pinsent Masons, Reddie & Grose, Spruson & Ferguson and Véron & Associés
10 July 2017 by
China is big. China is powerful. And now, China may be the best place in the world to file a patent lawsuit, says Erick Robinson of Beijing East IP